Biography

Yi has been working on tumor immunology and immunotherapy in multiple myeloma (MM) for 20 years. We were first to demonstrate the existence of idiotype-specific T cells in patients with MM and related disorders and that idiotype-specific cytotoxic T cells could lyse autologous primary myeloma cells.

Research Intrest

Antitumor immune response; C-reactive protein; Cancer; Drug resistance; Idiotype; Immunotherapy; Mantle cell lymphoma; Monoclonal antibodies; Multiple myeloma; T cells; Tumor microenvironment; Vaccines

List of Publications
Lu Y (2012) Th9 cells promote antitumor immune responses in vivo. J Clin Invest 122:4160-4171.
Qian J, (2012) Active vaccination with Dickkopf-1 induces protective and therapeutic antitumor immunity in murine multiple myeloma. Blood 119:161-169.
Zheng Y(2013) PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma. Leukemia 27:702--710.

Global Scientific Words in Medical Sciences